Martin Beer Selected Research

Classical Swine Fever (Swine Fever)

10/2019	Virus Adaptation and Selection Following Challenge of Animals Vaccinated against Classical Swine Fever Virus.
7/2017	Classical swine fever vaccines-State-of-the-art.
1/2017	A decade of research into classical swine fever marker vaccine CP7_E2alf (Suvaxyn® CSF Marker): a review of vaccine properties.
11/2016	Kinetics of maternally derived antibodies upon intramuscular vaccination against classical swine fever with Suvaxyn® CSF Marker (CP7_E2alf).
1/2016	Chimeric Pestivirus Experimental Vaccines.
6/2015	Classical swine fever virus marker vaccine strain CP7_E2alf: Shedding and dissemination studies in boars.
4/2014	First assessment of classical swine fever marker vaccine candidate CP7_E2alf for oral immunization of wild boar under field conditions.
2/2014	Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.
1/2014	Development and validation of a harmonized TaqMan-based triplex real-time RT-PCR protocol for the quantitative detection of normalized gene expression profiles of seven porcine cytokines.
11/2013	[Possibilities and limitations in veterinary vaccine development using the example of classical swine fever].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Beer Research Topics

Disease

74	Infections 12/2022 - 10/2002
28	Influenza in Birds (Avian Flu) 05/2021 - 02/2007
17	Classical Swine Fever (Swine Fever) 10/2019 - 03/2007
14	Diarrhea 01/2022 - 03/2003
11	Virus Diseases (Viral Diseases) 12/2019 - 03/2007
10	COVID-19 01/2022 - 01/2020
10	Human Influenza (Influenza) 01/2020 - 10/2010
6	Viremia 05/2021 - 04/2004
4	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 01/2014
4	Communicable Diseases (Infectious Diseases) 10/2015 - 08/2007
3	Necrosis 01/2014 - 11/2007
2	Rubella (German Measles) 01/2022 - 10/2020
2	Zoonoses 01/2022 - 11/2021
2	Thrombosis (Thrombus) 01/2022 - 12/2021
2	Thrombocytopenia (Thrombopenia) 01/2022 - 12/2021
2	Inflammation (Inflammations) 01/2021 - 01/2013
2	Disease Progression 12/2020 - 06/2014
2	Rabies (Hydrophobia) 01/2019 - 01/2017
2	Orthomyxoviridae Infections 11/2016 - 07/2013
2	African Swine Fever 05/2015 - 04/2013
1	Coinfection 03/2022
1	Animal Diseases 01/2022
1	Calculi (Calculus) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2022
1	Superinfection 01/2022
1	Dyskinesias (Dyskinesia) 01/2022
1	Dysbiosis 01/2021
1	Foot-and-Mouth Disease 01/2020
1	Acute Disease 01/2020
1	Lumpy Skin Disease 01/2020
1	Bunyaviridae Infections 01/2020
1	Rhinitis 01/2020
1	Hepatitis D 01/2020
1	Borna Disease 12/2019

Drug/Important Bio-Agent (IBA)

57	VaccinesIBA 06/2022 - 10/2002
18	AntibodiesIBA 01/2022 - 04/2007
17	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2003
13	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2003
13	Neuraminidase (Sialidase)IBA 01/2021 - 02/2007
12	Marker VaccinesIBA 01/2022 - 03/2007
11	Hemagglutinins (Hemagglutinin)IBA 05/2021 - 02/2009
8	AntigensIBA 06/2021 - 11/2007
6	Biological ProductsIBA 01/2022 - 05/2015
5	Glycoproteins (Glycoprotein)IBA 01/2021 - 07/2007
5	Inactivated VaccinesIBA 12/2020 - 10/2010
5	Complementary DNA (cDNA)IBA 01/2020 - 03/2003
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 10/2002
3	Viral RNAIBA 01/2021 - 01/2020
3	Viral AntigensIBA 01/2021 - 01/2017
3	Amino Acids FDA Link 10/2020 - 01/2014
3	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 10/2017 - 01/2012
3	EnzymesIBA 01/2015 - 03/2010
3	ImmunosorbentsIBA 01/2015 - 03/2010
3	Neutralizing AntibodiesIBA 12/2013 - 04/2004
2	COVID-19 VaccinesIBA 01/2022 - 12/2021
2	Capsid Proteins (Capsid Protein)IBA 01/2022 - 10/2020
2	Edetic Acid (EDTA)FDA Link 01/2022 - 02/2021
2	InterferonsIBA 12/2021 - 01/2018
2	Nucleic AcidsIBA 11/2021 - 01/2020
2	EpitopesIBA 10/2020 - 06/2011
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2016
2	CytokinesIBA 01/2018 - 01/2014
2	Viral ProteinsIBA 01/2018 - 01/2015
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2014 - 01/2014
2	feralIBA 02/2014 - 04/2013
2	A-Form DNA (A-DNA)IBA 09/2009 - 10/2002
1	Drinking WaterIBA 12/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	SolutionsIBA 01/2022
1	RG-4 (RG 4)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 12/2021
1	ChAdOx1 nCoV-19IBA 12/2021
1	Monoclonal AntibodiesIBA 11/2021
1	Virulence Factors (Pathogenicity Factors)IBA 05/2021
1	Cell Surface ReceptorsIBA 01/2021
1	Glyphosate (Roundup)IBA 01/2021
1	AngiotensinsIBA 01/2021
1	PlasminogenIBA 01/2021
1	Lysine (L-Lysine)FDA Link 10/2020
1	SuspensionsIBA 10/2020
1	Glutamic Acid (Glutamate)FDA Link 10/2020
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 10/2020
1	NucleotidesIBA 01/2020
1	Lysergic Acid Diethylamide (LSD)IBA 01/2020
1	Heparin Lyase (heparin lyase)IBA 01/2020
1	MVA vaccineIBA 01/2020
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2020
1	Catalytic RNA (Ribozymes)IBA 01/2020
1	hammerhead ribozymeIBA 01/2020
1	Single-Domain AntibodiesIBA 01/2020
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2020
1	Viral VaccinesIBA 01/2020
1	Immunoglobulin G (IgG)IBA 12/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Immunoglobulin M (IgM)IBA 01/2019
1	Glutamine (L-Glutamine)FDA Link 01/2019

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2016
1	Bioreactors (Bioreactor) 01/2019